Best Value Stocks by ST Score
Top 30 results, ranked from our full US coverage.
Each stock here earns a valuation grade of B or better, meaning it looks cheap relative to other companies in its sector on the multiples that matter.
Grades are relative, not absolute: a B in valuation says the shares are cheaper than most sector peers, not that they are cheap in isolation.
The list is ranked by overall ST Score so that cheap companies with sound fundamentals rise above cheap companies in trouble.
| # | Symbol | Company | Sector | Price | Market cap | Grade | Analysts | ST Score |
|---|---|---|---|---|---|---|---|---|
| 1 | CAAS | China Automotive Systems, Inc. | Consumer Cyclical | $5.08 | $153.3M | A- | — | 78.9 |
| 2 | JCSE | JE Cleantech Holdings Limited | Industrials | $1.46 | $7.7M | A- | — | 78.8 |
| 3 | EXG | Eaton Vance Tax-Managed Global Diversified Equity Income Fund | Financial Services | $9.62 | $2.94B | A- | Hold | 78.3 |
| 4 | CLIK | Click Holdings Limited | Industrials | $1.22 | $771,285 | B+ | — | 74.7 |
| 5 | ODTX | Odyssey Therapeutics, Inc. | Healthcare | $24.38 | $1.17B | B+ | Buy | 74.7 |
| 6 | SBCWW | SBC Medical Group Holdings Incorporated | Industrials | $0.35 | $35.7M | B+ | — | 74.1 |
| 7 | SLDE | Slide Insurance Holdings, Inc. Common Stock | Financial Services | $24.95 | $2.91B | B+ | Buy | 73.6 |
| 8 | BLSM | BlossomHill Therapeutics, Inc. | Healthcare | $26.80 | $779.4M | B+ | — | 71.8 |
| 9 | IX | ORIX Corporation | Financial Services | $39.30 | $43.63B | B+ | — | 70.3 |
| 10 | BNC | CEA Industries Inc. Common Stock | Industrials | $6.57 | $270.5M | B+ | — | 69.4 |
| 11 | ELOX | Eloxx Pharmaceuticals, Inc. | Healthcare | $17.19 | $59.1M | B+ | Buy | 69.3 |
| 12 | IFRX | InflaRx N.V. | Healthcare | $2.09 | $307.8M | B+ | Buy | 69.2 |
| 13 | YB | Yuanbao Inc. American Depositary Shares | Technology | $12.40 | $95.3M | B+ | — | 69.1 |
| 14 | CBL | CBL & Associates Properties, Inc. | Real Estate | $53.51 | $1.66B | B+ | Hold | 68.8 |
| 15 | SIBN | SI-BONE, Inc. | Healthcare | $18.09 | $802.3M | B+ | Buy | 68.6 |
| 16 | DAKT | Daktronics, Inc. | Technology | $17.66 | $852.7M | B | Buy | 67.8 |
| 17 | AXS | AXIS Capital Holdings Limited | Financial Services | $97.97 | $7.15B | B | — | 66.7 |
| 18 | SELF | Global Self Storage, Inc. | Real Estate | $5.03 | $57.5M | B | Buy | 66.7 |
| 19 | SGMT | Sagimet Biosciences Inc. | Healthcare | $11.09 | $361.3M | B | Buy | 66.4 |
| 20 | AGMB | AgomAb Therapeutics N.V. American Depositary Shares | Healthcare | $11.70 | $576.2M | B | — | 66.1 |
| 21 | ENIC | Enel Chile S.A. | Utilities | $4.31 | $5.96B | B | Hold | 66.1 |
| 22 | GSM | Ferroglobe PLC | Basic Materials | $4.18 | $787.2M | B | Buy | 66.1 |
| 23 | AMN | AMN Healthcare Services, Inc. | Healthcare | $34.24 | $1.33B | B | Buy | 65.8 |
| 24 | IKT | Inhibikase Therapeutics, Inc. | Healthcare | $2.30 | $303.7M | B | — | 65.8 |
| 25 | PBR-A | Petróleo Brasileiro S.A. - Petrobras | Energy | $18.82 | $121.28B | B | Buy | 65.8 |
| 26 | YALA | Yalla Group Limited | Technology | $5.44 | $840.0M | B | Buy | 65.7 |
| 27 | CERS | Cerus Corporation | Healthcare | $2.56 | $515.9M | B | Buy | 65.6 |
| 28 | FRD | Friedman Industries, Incorporated | Basic Materials | $41.21 | $297.2M | B | — | 65.6 |
| 29 | SMTAX | JPMorgan SmartRetirement 2040 Fund Class A | Financial Services | $25.41 | $3.68B | B | — | 65.6 |
| 30 | CHTRP | Charter Communications, Inc. Series A Cumulative Redeemable Preferred Stock | Communication Services | $22.87 | $164.3M | B | — | 65.5 |
Want to change the thresholds? Open the full stock screener and adjust any of the 100+ filters.
Frequently asked questions
What makes a stock a value stock?
A value stock trades at a low price relative to its earnings, cash flow, sales or book value compared with its peers. Our valuation grade measures exactly that, against sector medians.
How is the valuation grade calculated?
We compare a company's valuation multiples with its sector peers and place it on that curve, from A+ down to F.
Can a cheap stock still be a bad investment?
Yes. Low multiples sometimes reflect falling earnings or a weak balance sheet — a 'value trap'. Check the profitability and financial strength grades alongside valuation.
Why rank by ST Score instead of P/E?
The ST Score combines valuation with growth, profitability, financial strength and momentum, which surfaces cheap companies that are also healthy.
Popular screens
Ready-made lists built from the same data — no filters to set.